Journal profile

Journal of women's health

Publisher: SAGE Publications
ISSN1540-9996 | 1931-843X | 1540-9996 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.41
Citation rate 2.23 914 total citations
h5-index 42 h5 depth signal
Cited share 72.4% 315 of 435
Total citations 914 Citation footprint
Metric signal 1.93 External metric anchor
Self-citation 2.4% 22 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 1,869
Canada 79
China 54
Australia 46
South Korea 35

Citing Fields of Research

Obstetrics/Gynecology 615
Reproductive Health 535
Healthcare Policy 297
Psychiatry & Psychology 195
Human Reproduction 182

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 5,442 Articles tracked across the journal lifetime
Indexed publication set 435 315 cited publications
Last 12 months 189 15.8 publications/month
Open access share 6.3% 12 OA publications in the last year
Leading citing country United States 1,869 citing publications
Leading citing field Obstetrics/Gynecology 615 citing publications
Latest tracked publication 17 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v11n8,Oct. 2002-
PubMed
v11n8,Oct. 2002-
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Reproductive Health Obstetrics/Gynecology Healthcare Policy Human Reproduction Patient Care Substance Abuse

Broad Categories

Gynecology Women's Health Obstetrics/Gynecology Reproductive Health Patient Care Human Reproduction Psychiatry & Psychology Urology

MeSH Descriptors

Genital Diseases, Female Women's Health

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01
Rebecca E. Moritz, Erin Whitney, Deanna Fink et al.
Introduction: The United States has no national cervical cancer screening registry and available data sources for estimating screening have limitations: population surveys may overestimate screening and insurance claims data are nonrepre...
02
Melissa R. Schick, Ashley Clayton, Christopher D. Maxwell et al.
Background: Men’s substance use influences their intimate partner violence (IPV) perpetration and women’s assessment of their IPV-related risk. Women actively protect themselves using various strategies to stop, prevent, or escape confli...
05
Hyo-Jung Choi, Flor Arellano, Rebecca Dudovitz et al.
Purpose: Pregnant women with low incomes and racial/ethnic minorities experience higher rates of maternal depression and anxiety, which negatively impact maternal and infant well-being. Racial minorities experience increased stress due t...
08
Jersey-Kate Castillo, Daniel Jhang, Jason L. Lui et al.
Introduction: Polyacrylamide hydrogel (PAHG) is a urethral bulking agent for stress urinary incontinence (SUI) that received FDA approval in 2020. In mixed urinary incontinence (MUI), PAHG may be used concomitantly with onabotulinumtoxin...
09
Sun Hee Rim, Jean Colbert, Emily Kobernik et al.
Background: Clinical practice guidelines for cancer screening and management are developed by multiple guideline organizations and published in narrative form. However, guideline concordance can be challenging due to several factors: rap...
10
Kehui Teoh, Christina M. Seeger, Paul W. Zarutskie
Background: Thyroid autoimmunity (TAI) is the most common autoimmune condition affecting women of reproductive age. Prior studies have linked TAI to adverse reproductive outcomes; however, antibody-specific effects and their relative cli...

Bibliographical & Catalog Notes

Title from cover.

Last issue consulted: Vol. 11, no. 10 (Dec. 2002).

Also issued online.

Complemented by: Women's health reports.

Complemented by (work): Women's health reports (New Rochelle, N.Y.) 2688-4844 (DLC) 2019200573 (OCoLC)1111735682 (DNLM)101768931.